Ronald Levy of Stanford University Medical Center in California and his colleagues have carried out the first clinical trial of plant produced therapeutic vaccines against non- Hodgkin’s lymphoma. The vaccines were grown in tobacco plants by infecting the plants with a tobacco mosaic virus containing
DNA fragments cloned from each patient’s cancer cells, thus matching each vaccine to its potential beneficiary. Eleven of the 16 participants with the cancer had developed a cellular immune response 28 days after vaccination; six of these made antibodies specific to certain proteins found on the surface of their cancerous white blood cells.

Vitamin C and Cancer Revisited

Moving Ahead with an International Human Epigenome Project

Shrewd Survival Strategy ( Tuberculosis )

World Bank Biofuels Report Finally Released :
The combination of higher energy prices and related increases in fertilizer prices and transport costs, and dollar weakness caused food prices to rise by about 35-40 percentage points from January 2002 until June 2008.